Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
Apr 29, 2009	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-09-000014.pdf 0001237899-09-000014.xls
Apr 24, 2009	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	View HTML 0001206774-09-000860.pdf 0001206774-09-000860.xls
Apr 15, 2009	3	Initial filing by director officer or owner of more than ten percent.	View HTML 0001237899-09-000013.pdf 0001237899-09-000013.xls
Feb 26, 2009	10-K	Annual report which provides a comprehensive overview of the company for the past year	View HTML 0001206774-09-000338.pdf 0001206774-09-000338.xls
Feb 26, 2009	8-K	Report of unscheduled material events or corporate event	View HTML 0001206774-09-000352.pdf 0001206774-09-000352.xls
Feb 24, 2009	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-09-000010.pdf 0001237899-09-000010.xls
Feb 24, 2009	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-09-000011.pdf 0001237899-09-000011.xls
Feb 17, 2009	SC 13G/A	An amendment to the SC 13G filing	View HTML 0000902219-09-000912.pdf 0000902219-09-000912.xls
Feb 17, 2009	SC 13G/A	An amendment to the SC 13G filing	View HTML 0000315066-09-002068.pdf
Feb 13, 2009	SC 13G/A	An amendment to the SC 13G filing	View HTML 0000312348-09-000034.pdf

Data provided by Kaleidoscope.

Investors & Media